Introduction:
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy.
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medications Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients. The tablets are used in combination with Capecitabine or Letrozole, which together inhibit the growth of cancer cells in patients.
Instructions:
Your doctor or nurse will give you this medicine. Kindly do not self-administer. It is used to treat metastatic breast cancer (cancer that has been spread to other parts of the body from the breast).
Side Effects:
- Nausea,
- Vomiting,
- Weakness,
- Indigestion,
- Constipation,
- Sore mouth,
- Trouble sleeping,
- Back pain,
- Joint pain,
- Headache,
- Hot flushes,
- Hir loss,
- Nail disorder and
- Abnormal heartbeat.
Want to know more?
Read Our Editorial PolicyWhat our Users have to say
4000+ products
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
Secure Payment
100% secure and trusted payment protection
Easy Return
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.